Tirzepatide's CV Benefit; PREVENT Age Calculator; Rectal Injection for BP Reduction?

(MedPage Today) — The GIP/GLP-1 dual agonist tirzepatide (Mounjaro) showed cardiovascular protective benefits over dulaglutide (Trulicity) in the phase III SURPASS-CVOT trial of diabetes patients with heart disease, Lilly announced.
The FDA approved…

Source link : https://www.medpagetoday.com/cardiology/generalcardiology/116835

Author :

Publish date : 2025-08-05 17:02:00

Copyright for syndicated content belongs to the linked Source.

M	T	W	T	F	S	S
1	2	3	4	5	6	7
8	9	10	11	12	13	14
15	16	17	18	19	20	21
22	23	24	25	26	27	28
29	30

Tirzepatide’s CV Benefit; PREVENT Age Calculator; Rectal Injection for BP Reduction?

Novel Combination Shows Efficacy, Safety in Mid-Stage MASH Trial

Trump Administration Wants to End VA’s Abortion Coverage

Related Posts

New and Improved Postmastectomy RT Guideline Released

GLP-1s Benefit Patients With RA and Overweight or Obesity

MS Drug Decision Delayed; Levodopa for Stroke Recovery; Boosting Astrocytic NAD+

Screen for Cannabis Use in Pregnancy, Guidance Says

Mapping the structure of the brain doesn’t fully explain its function

Head Strikes: A Concern for Anesthesia and Nursing Teams

New and Improved Postmastectomy RT Guideline Released

GLP-1s Benefit Patients With RA and Overweight or Obesity

MS Drug Decision Delayed; Levodopa for Stroke Recovery; Boosting Astrocytic NAD+

Screen for Cannabis Use in Pregnancy, Guidance Says

Mapping the structure of the brain doesn’t fully explain its function

Head Strikes: A Concern for Anesthesia and Nursing Teams

Mammogram-CVD Screens; Heavy Metals and Pregnancy BP; Worst Cheese for the Heart?

Molecular Imaging Boosted Cancer Detection in Women With Dense Breasts

Categories

Archives